| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |